Table 5. Exposure of Compound 18 following Dosing Prodrug 19 in Mouse Acanthosis.
| dose (mg/kg QD)a | 5 | 15 | 45 |
|---|---|---|---|
| day 1 AUCtot (μM-h) | 13.9 | 30.9 | 274.3 |
| day 9 AUC24 (μM-h) | 9.0 | 45.2 | 162.9 |
| day 9 Cmax (μM) | 0.65 ± 0.19 | 2.58 ± 0.36 | 8.34 ± 2.26 |
| day 1 C24h (μM) | 0.21 ± 0.08 | 0.48 ± 0.14 | 0.91 ± 0.33 |
| day 9 C24h (μM) | 0.15 ± 0.08 | 1.36 ± 0.56 | 5.82 ± 1.10 |
| day 9 C24h fold mouse Th17 IC90b | 0.4× | 3.2× | 13.9× |
Prodrug was dosed to provide the indicated amount of parent after phosphate hydrolysis; solution vehicle: 20% of 0.1 M acetate buffer; 80% PEG 400.
Protein binding adjusted mouse Th17 IC90 = 0.42 μM